Relay Therapeutics, Inc.

NASDAQ:RLAY

Biotechnology

Healthcare
$15.91 +2.63%

+$0.41 today

Market cap
$3.52B
Beta
1.75
P/E (TTM)
-10.5
EPS (TTM)
-$1.52
52W Low $3.03High $17.47

Volume 1.88M

Average 3.70M

Balance Sheet

Inspect the capital base behind the business.

Assets

$621.33M

FY 2025 · Annual

-28.7% YoY

Liabilities

$54.27M

FY 2025 · Annual

-42.0% YoY

Equity

$567.06M

FY 2025 · Annual

-27.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents280.12M151.79M143.74M124.29M84.02M
Short-term Investments677.95M847.12M606.35M657.04M470.5M
Net Receivables4.94M5.22M000
Inventory012.11M000
Other Current Assets1.76M3.26M3.32M10.53M5.97M
Total Current Assets976.24M1.02B770.1M809.2M578.28M
Property, Plant & Equipment (Net)27.32M75.39M68.87M57.67M41.72M
Goodwill00000
Intangible Assets2.3M2.3M2.3M2.3M0
Long-term Investments02.58M2.71M01.34M
Tax Assets0(2.58M)000
Other Non-current Assets2.58M2.58M02.12M0
Total Non-current Assets32.2M80.27M73.88M62.09M43.05M
Total Assets1.01B1.1B843.98M871.3M621.33M
Account Payables8.28M10.58M9.21M14.1M7.71M
Short-term Debt00000
Tax Payables00000
Deferred Revenue248K007.68M0
Other Current Liabilities989K26.15M1.91M2.1M463K
Total Current Liabilities24.32M63.71M30.27M50.73M25.58M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities65.26M32.38M13.21M00
Total Non-current Liabilities86.31M85.84M61.71M42.78M28.69M
Total Liabilities110.64M149.55M91.98M93.5M54.27M
Common Stock109K121K127K168K168K
Retained Earnings(768.1M)(1.06B)(1.4B)(1.74B)(2.01B)
Accumulated OCI(1.09M)(10.42M)(196K)(991K)733K
Other Stockholders Equity00000
Minority Interest00000
Total Equity897.81M950.22M752M777.79M567.06M
Total Debt22.9M57.74M53.47M48.5M32.46M
Net Debt(257.22M)(94.05M)(90.27M)(75.79M)(51.56M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$121.2M
Short-term Investments$789.7M
Other Current$17.1M
Total Current Assets$928.1M
PP&E (Net)$38.0M
Long-term Investments$1.3M
Total Non-current Assets$39.4M
Total Assets$967.5M

Analysis

Selected assets total $967.5M for Latest. The largest visible component is Short-term Investments at $789.7M, about 81.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
4Statement of changes in beneficial ownershipOct 30, 2026

How much cash does RLAY have?

Relay Therapeutics, Inc. (RLAY) reported $84.02M in cash and equivalents in fiscal 2025.

How much debt does RLAY carry?

Relay Therapeutics, Inc. (RLAY) reported $32.46M of total debt, with net debt of -$51.56M.